Stay updated on MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.

Latest updates to the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAddition: Revision: v3.3.3 was added to the Record History; Deletions: HHS Vulnerability Disclosure and Revision: v3.3.2 were removed, reflecting maintenance and versioning rather than study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedAdded Revision: v3.3.2 to the page history and removed Revision: v3.2.0.SummaryDifference0.1%

- Check52 days agoChange DetectedThe notice about government funding and operating status was removed from the page.SummaryDifference0.5%

- Check67 days agoChange DetectedThe new screenshot shows only a visual/layout refresh of the Record History page without changes to the version data or study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check95 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference11%

- Check103 days agoChange DetectedUpdates the page version from v3.0.2 to v3.1.0, updating the core metadata/document revision tag.SummaryDifference0.3%

Stay in the know with updates to MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.